GlassScriptPhysician profile
Clare E Reinhardt
NPI 1740374966
$1,362.82
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $203 · 2021: $400 · 2022: $432 · 2023: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $332.06 | 2021-2023 | Puraply |
| Smith+Nephew, INC. | $329.85 | 2020-2023 | Oasis, Grafix Pl, Collagenase Santyl |
| Next Science LLC | $170.91 | 2022-2023 | Blastx, Xperience, Surgx |
| Integra Lifesciences Corporation | $122.62 | 2020-2022 | |
| Ovik Health, LLC | $91.32 | 2021-2022 | |
| Kci USA, INC. | $71.10 | 2020-2022 | |
| Abbvie INC. | $58.06 | 2021-2023 | |
| Paratek Pharmaceuticals, INC. | $41.32 | 2023 | Nuzyra |
| Kerecis Limited | $39.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hartmann USA, INC. | $22.64 | 2020 | |
| Advanced Oxygen Therapy INC. | $21.25 | 2023 | Topical Oxygen Chamber For Extremities |
| Urgo Medical North America, LLC | $19.99 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Urgok2 |
| Molnlycke Health Care US, LLC | $19.26 | 2022 | |
| Convatec INC. | $16.80 | 2021 | |
| Aroa Biosurgery Incorporated | $6.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Reinhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.